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Abstract
The CRISPR-Cas9 system is a powerful genome-editing tool that promises application for gene 
editing therapies. The Cas9 nuclease is directed to the DNA by a programmable single guide 
(sg)RNA, and introduces a site-specific double-stranded break (DSB). In mammalian cells, DSBs 
are either repaired by non-homologous end joining (NHEJ), generating small insertion/deletion 
(indel) mutations, or by homology-directed repair (HDR). If ectopic donor templates are provided, 
the latter mechanism allows editing with single-nucleotide precision. The preference of 
mammalian cells to repair DSBs by NHEJ rather than HDR, however, limits the potential of 
CRISPR-Cas9 for applications where precise editing is needed. To enhance the efficiency of DSB 
repair by HDR from donor templates, we recently engineered a CRISPR-Cas9 system where the 
template DNA is bound to the Cas9 enzyme. In short, single-stranded oligonucleotides were 
labeled with O6-benzylguanine (BG), and covalently linked to a Cas9-SNAP-tag fusion protein to 
form a ribonucleoprotein-DNA (RNPD) complex consisting of the Cas9 nuclease, the sgRNA, and 
the repair template. Here, we provide a detailed protocol how to generate O6-benzylguanine (BG)-
linked DNA repair templates, produce recombinant Cas9-SNAP-tag fusion proteins, in vitro 
transcribe single guide RNAs, and transfect RNPDs into various mammalian cells.
Keywords
CRISPR-Cas9; Genome editing; Template linkage; Homology-directed repair; Precise editing; 
Enhanced correction
Background
The CRISPR-Cas9 system efficiently induces site-directed DSBs, which are repaired by 
cell-autonomous mechanisms. Since mammalian cells predominantly repair DSBs by NHEJ, 
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the CRISPR-Cas9 system mainly causes indel mutations at targeted loci. For many 
applications, precise repair via HDR from template DNA is however desired. Hence, several 
attempts have been made to increase the efficiency of accurate DSB repair, including 
biochemical alteration the repair pathways (Chu et al., 2015; Maruyama et al., 2015; Yu et 
al., 2015; Song et al., 2016), limiting DSB-induction to the S/G2 phase of the cell cycle 
where HDR is active (Lin et al., 2014; Gutschner et al., 2016; Howden et al., 2016), and 
optimizing length and symmetry of the repair template (Hendel et al., 2015; Rahdar et al., 
2015; Yin et al., 2017; Richardson et al., 2016; Liang et al., 2017). In addition, several 
groups have recently demonstrated that temporal and spatial co-localization of the repair 
template to the Cas9 complex enhances HDR rates (Carlson-Stevermer et al., 2017; Aird et 
al., 2018; Gu et al., 2018; Savic et al., 2018). Importantly, these approaches do not involve 
any potentially harmful chemical treatment to alter endogenous cellular processes, and due 
to the shorter half-life of ribonucleoprotein complexes compared to DNA, they exhibit 
reduced risks of generating off-target mutations (Kim et al., 2014). In addition, procedures 
for clinical-grade recombinant protein production are well established, and progress has 
been made to deliver Cas9 RNP complexes in vivo in animal models (Zuris et al., 2015; 
Wang et al., 2016; Lee et al., 2017; Staahl et al., 2017). In summary, using Cas9 complexes 
with linked DNA repair templates is a promising approach for gene editing therapies, where 
high rates of precise repair is desired.
Here, we provide a detailed protocol for linking the DNA repair template to Cas9 as 
demonstrated in Savic et al., 2018. The described approach is based on the SNAP-tag 
technology, which enables the generation of a covalently linked Cas9-DNA complexes in 
vitro. We explain how to label repair-oligonucleotides with Benzylguanine (BG), how to 
produce Cas9-SNAP fusion proteins, how to produce single guide (sg)RNAs, how to 
generate DNA-ribonucleoprotein complexes in vitro, how to transfect them into mammalian 
cells, and how to analyze correction efficiencies (Figure 1).
Materials and Reagents
A. Materials
1. Syringe Luer 1 ml (Codan, catalog number: 3.7420.01)
2. Syringe Luer 10 ml (Codan, catalog number: 3.7410.06)
3. Hypodermic needle Luer, 22 G x 1¼ " (BD Microlane™, catalog 
number: 613-3928)
4. 24-well cell culture plate Cellstar® (Greiner Bio-One, catalog number: 
7662160)
5. 6-well cell culture plate Cellstar® (Greiner Bio-One, catalog number: 
7657160)
6. 10 cm tissue culture dish Cellstar® (Greiner Bio-One, catalog number: 
7664160)
7. μ-Slide 8-well glass bottom (Vitaris, Ibidi®, catalog number: 80827-
IBI)
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8. Centrifugation tube ED Safe-Lock 1.5 ml (Eppendorf, catalog number: 
0030120.086)
9. 10 μl, 20 μl, 200 μl, 1,000 μl pipette filter tips (Axon Lab AG, catalog 
numbers: AL60010, AL60020, AL60200, AL61000)
10. Centrifugation tubes PP 15 ml (Greiner Bio-One, catalog number: 
7188271)
11. 5 ml sterile polystyrene round bottom test tubes with cell strainer cap 
(12 x 75 mm) (Corning Life Sciences, Falcon®, catalog number: 
352235)
12. Safe-Lock microcentrifuge tubes (Eppendorf, catalog number: 0030 
120.086)
13. 5 ml, 10 ml, 25 ml, 50 ml polystryrene serological pipettes 
(SARSTEDT, catalog numbers: 86.1253.001, 86.1254.001, 
86.1685.001, 86.1256.001)
14. Tubes and flat caps, strips of 8 (Thermo Fisher Scientific, Thermo 
Scientific™, catalog number: AB1182)
15. Tubes, 0.2 ml, flat cap, individual tubes (Thermo Fisher Scientific, 
Thermo Scientific™, catalog number: AB0620)
16. 1.5 ml tube (SARSTEDT, catalog number: 72.690.001)
17. 1,000 ml Nalgene™ PPCO centrifuge bottles (Thermo Scientific™, 
catalog number: 3120-1000)
18. Nalgene™ Oak Ridge high-speed PPCO centrifuge tubes (Thermo 
Scientific™, catalog number: 3119-0050)
19. Deep well plate, 96-well (VWR, catalog number: 732-0585)
20. Ni-NTA Superflow (QIAGEN, catalog number: 30430)
21. XK16/20 empty column (GE Life Sciences, catalog number: 28988937)
22. HiTrap Heparin HP (GE Healthcare, catalog number: 17-0407-01)
23. HiLoad 16/600 Superdex 200 pg (GE Healthcare, catalog number: 
28989335)
24. Amicon Ultra-15, PLHK Ultracel-PL Membran, 100 kDa (Merck, 
catalog number: UFC910096)
25. 1 ml polypropylene tubes, CRYO.S (e.g., Greiner Bio-one, catalog 
number: 123279)
26. 1.5 ml screw neck vials and 200 μl glass inserts (e.g., BGB, catalog 
numbers: 080400 and 110501)
27. Waters XBridge Oligonucleotide BEH C18 column, 10 x 50 mm, 2.5 
μm (Waters, catalog number: 186008212)
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28. 0.2 μm vacuum filter (TPP, catalog number: 99255)
29. Glen Gel-Pak 1.0 desalting column (Glen research, catalog number: 
61-5010)
B. Cells
1. Human embryonic kidney (HEK293T) (ATCC, catalog number: 
CRL-3216)
2. Human blood (chronic myelogenous leukemia) (K562) (Sigma-Aldrich, 
catalog number: 89121407)
3. Mouse Embryonic Stem Cells (mESC, WT E14 line) (ATCC, catalog 
number: CRL-1821)
4. Rosetta™ 2 (DE3) Singles™ Competent Cells (Novagen, catalog 
number: 71400-3)
C. Reagents
1. pNS20-SpCas9-SNAP plasmid (Addgene, catalog number: 113717)
2. Synthetic oligonucleotides with a ‘5-Amino Modifier C6 functional 
group (Integrated DNA Technologies)
3. Benzylguanine-GLA-NHS (New England Biolabs, catalog number: 
S9151S)
4. HEPES (Sigma-Aldrich, catalog number: H4034-500G)
5. N, N-Dimethylformamide (DMF) (Sigma-Aldrich, catalog number: 
227056-250ML)
6. TrypLE™ Express Enzyme (1x), phenol red (Thermo Fisher Scientific, 
Gibco™, catalog number: 12605010)
7. Sytox™ Red Dead Cell Stain (Thermo Fisher Scientific, Invitrogen™, 
catalog number: S34859)
8. Recombinant protein Streptococcus pyogenes (SpCas9-SNAP) (Savic et 
al., 2018)
9. Recombinant protein Staphylococcus aureus (SadCas9-SNAP) (Savic et 
al., 2018)
10. Phosphate buffered saline (PBS), pH 7.4 (Thermo Fisher Scientific, 
Gibco™, catalog number: 10010023)
11. Penicillin-streptomycin solution (Pen-Strep) (10,000 U/ml) (Thermo 
Fisher Scientific, Gibco™, catalog number: 15140122)
12. Fetal bovine serum (FBS) (Sigma-Aldrich, catalog number: F7524)
13. Fetal bovine serum (FBS) (Thermo Fisher Scientific, Life Technologies, 
catalog number: 10270106) for mESC culture
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14. Dulbecco’s modified Eagle’s medium (high glucose) (DMEM) 
(Thermo Fisher Scientific, Gibco™, catalog number: 31966021) for 
HEK293T culture
15. Dulbecco’s modified Eagle’s media (DMEM) (Sigma-Aldrich, catalog 
number: D6429-500ML) for mESC culture
16. RPMI 1640 medium, GlutaMAX™ supplement (Thermo Fisher 
Scientific, Gibco™, catalog number: 61870010) for K562 culture
17. LIF (Millipore, catalog number: ESG1107)
18. 2-β-mercaptoethanol (Thermo Fisher Scientific, Life Technologies, 
catalog number: 31350-010)
19. Gelatin from porcine skin powder gel (Sigma-Aldrich, catalog number: 
G1890-500G)
20. Poly-L-lysine (Sigma, catalog number: P1524)
21. Trypsin-EDTA (0.05%), phenol red (Thermo Fisher Scientific, 
Gibco™, catalog number: 25300054)
22. Lipofectamine™ 2000 transfection reagent (Thermo Fisher Scientific, 
Invitrogen™, catalog number: 11668019)
23. Opti-MEM™ I reduced serum medium, no phenol red (Thermo Fisher 
Scientific, Gibco™, catalog number: 11058021)
24. Hoechst 33342 solution (20 mM) (Thermo Fisher Scientific, Thermo 
Scientific™, catalog number: 62249)
25. Glycogen (Roche, catalog number: 10901393001)
26. 3 M sodium acetate buffer solution (NaAc) (Sigma-Aldrich, catalog 
number: S7899-100ML)
27. Ethanol (Merck, catalog number: 100983)
28. Isopropanol (Merck, catalog number: 109634)
29. Water, 0.1 μm filtered, double distilled, deionized, nuclease/protease-
free (Sigma-Aldrich, catalog number: W4502)
30. EDTA disodium salt 2-hydrate for molecular biology (AppliChem, 
catalog number: A2937)
31. GelRed nucleic acid gel stain 10,000x in DMSO (Biotium, catalog 
number: 41002)
32. IVT primers (Integrated DNA Technologies, 100 nmole DNA oligos)
33. Phusion polymerase (New England Biolabs, catalog number: M0530)
34. Deoxynucleotide (dNTP) Solution Mix (New England Biolabs, catalog 
number: M0447)
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35. QIAquick PCR Purification Kit (QIAGEN, catalog number: 28106)
36. Gel 6x Loading Dye, Purple (New England Biolabs, catalog number: 
B7024S)
37. LE agarose, multi-purpose agarose (Clever Scientific, catalog number: 
CSL-AG)
38. DEPC-treated water (Thermo Fisher Scientific, Invitrogen™, catalog 
number: AM9916)
39. RNA Polymerase, T7 (Roche, catalog number: 10881767001)
40. NTP Set, 100 mM solution (Thermo Fisher Scientific, Thermo 
Scientific™, catalog number: R0481)
41. RNase-free DNase set (QIAGEN, catalog number: 79254)
42. Ammonium acetate solution, BioUltra 5M (Sigma-Aldrich, catalog 
number: 09691)
43. RNA Clean & Concentrator (Zymo Research, catalog number: R1017)
44. RNase AWAY (Sigma-Aldrich, catalog number: 83931)
45. Ambion® NorthernMax® formaldehyde load dye (Thermo Fisher 
Scientific, Invitrogen™, catalog number: AM8552)
46. Formaldehyde 37% in H2O (Sigma-Aldrich, catalog number: 252549)
47. Low Range ssRNA ladder (New England Biolabs, catalog number: 
N0264)
48. SYBR™ Gold nucleic acid gel stain, 10,000x Concentrate in DMSO 
(Thermo Fisher Scientific, Invitrogen™, catalog number: S11494)
49. 1,1,1,3,3,3-Hexafluoro-2-propanol (Fluorochem, catalog number: 
003409)
50. RNase-free ultrapure H2O (purified on our EMD Millipore Synergy UV 
system)
51. Methanol (VWR, catalog number: 20864.320)
52. Triethylamine puriss, p.a. > 99.5% (Sigma-Aldrich, catalog number: 
90340)
53. Acetic acid puriss, p.a. > 99.8% (Sigma-Aldrich, catalog number: 
33209)
54. DNeasy Blood and Tissue kit (QIAGEN, catalog number: 69506)
55. NEBNext® high-fidelity 2x PCR master mix (New England Biolabs, 
catalog number: M0541L)
56. Agencourt AMPure XP reagent (Beckman Coulter, catalog number: 
A63881)
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57. Index adaptor sequences, HPLC quality (Integrated DNA Technologies)
58. LB-agar (Luria/Miller) (Carl Roth, catalog number: X969.2)
59. LB medium (Miller) pulver (Faust Laborbedarf AG, catalog number: 
6.271 000)
60. Kanamycinsulfat (Carl Roth, catalog number: T832.4)
61. Isopropyl-β-D-thiogalactopyranosid (IPTG) (Chemie Brunschwig AG, 
catalog number: BP1755-100)
62. HEPES 200 mM pH 8.5 (see Recipes)
63. HEK293T medium (see Recipes)
64. K562 medium (see Recipes)
65. mESC proliferative growth medium (see Recipes)
66. Gelatin solution 0.2% (see Recipes)
67. Poly-L-lysine solution 0.2% (see Recipes)
68. FACS buffer (see Recipes)
69. EDTA buffer 0.5 M pH 8.0 (see Recipes)
70. Protein buffer (see Recipes)
71. KCl buffer 500 mM (see Recipes)
72. 3-(N-morpholino) propanesulfonic acid (MOPS) 10x running buffer 
(see Recipes)
73. Tris-borate-EDTA (TBE) 10x buffer (see Recipes)
74. Tris buffer 1 M (see Recipes)
75. TE buffer pH 8.0 (see Recipes)
76. HPLC eluent A (see Recipes)
77. LC/MS eluent A (see Recipes)
78. Chloramphenicol 1,000x (34 mg/ml stock) (see Recipes)
79. Kanamycin 1,000x (50 mg/ml stock) (see Recipes)
80. IPTG 1 M (see Recipes)
81. NaCl 5 M (see Recipes)
82. DTT 1 M (see Recipes)
83. Imidazole 2.5 M pH 8.0 (see Recipes)
84. HEPES 1 M pH 7.5 (see Recipes)
85. Protease inhibitor (1:1,000) (see Recipes)
86. KCl 4 M (see Recipes)
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87. Tris buffer 1 M pH 6.8 (see Recipes)
88. Lysis buffer (see Recipes)
89. Wash buffer (see Recipes)
90. Elution buffer (see Recipes)
91. Heparin buffer A (see Recipes)
92. Heparin buffer B (see Recipes)
93. SEC buffer (see Recipes)
94. 1x Laemmli buffer (see Recipes)
95. 5x Laemmli buffer (see Recipes)
Equipment
1. 250 ml Erlenmeyer flask (Huberlab AG, catalog number: 9.0460.63)
2. 2 L Erlenmeyer flask (Carl Roth, catalog number: C141.2)
3. Pipetman G P2G, P10G, P20G, P200G, P1000G (Gilson, catalog numbers: 
F144054P, F144055M, F144056P, F144058P, F144059P)
4. Pipette controller, Pipet-Aid® Hood Mate® (Drummond, catalog number: 
4-000-302)
5. Laminar flow hood SafeFAST Premium (FASTER S.r.l, catalog number: 
F00024900000)
6. T100™ thermal cycler (Bio-Rad, catalog number: 1861096)
7. NanoDrop 2000 spectrophotometer (Thermo Fisher Scientific, Thermo 
Scientific™, model: NanoDrop™ 2000, catalog number: ND-2000)
8. Tissue culture incubator set at 37 °C, 5% CO2 (Thermo Fisher Scientific, 
Thermo Scientific™, model: Heracell™ 150i, catalog number: 51026283)
9. Vortex-Genie 2 (Scientific Industries, model: Vortex-Genie 2, catalog number: 
SI-0276)
10. AREX digital PRO magnetic stirrer with hot plate (Velp Scientifica, catalog 
number: SA20500411)
11. Centrifuge Micro Star 17 (VWR, catalog number: 521-1646)
12. Microcentrifuge, MiniStar silverline (VWR, catalog number: 521-2845)
13. Microlitre centrifuge (Hermle Labortechnik, catalog number: Z216MK)
14. Countess automated cell counter (Thermo Fisher Scientific, Invitrogen™, catalog 
number: C10227)
15. Countess® cell counting chamber slides (Thermo Fisher Scientific, Invitrogen™, 
catalog number: C10228)
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16. BD LSR Fortessa cell analyser (Becton-Dickinson)
17. Thermoshaker, cooling thermal shake touch (VWR, catalog number: 460-0198)
18. Microwave oven (Primotecq, catalog number: MW 5920)
19. TW12 water bath (Julabo, catalog number: 9550112)
20. Wide Mini-Sub® Cell GT horizontal electrophoresis system, 15 x 10 cm tray 
(BioRad, catalog number: 1704468)
21. ChemiDoc XRS gel imaging system (Bio-Rad, catalog number: 1708265)
22. Liquid chromatography-mass spectrometry system and software for peak 
analysis (e.g., Agilent 1200 Series HPLC [Agilent Technologies, model: 1200 
Infinity Series] connected to an Agilent 6130 Series Quadrupole [Agilent 
Technologies, model: 6130 Series])
23. Waters Acquity UPLC C18 column, 2.1 x 50 mm, 1.7 μm (Waters, catalog 
number 186003949)
24. Centrifugal concentrator (e.g., Genevac, miVac Duo, catalog number: 
DUC-23050-B00)
25. Water purification system (e.g., EMD Millipore Synergy UV equipped with a 
Biopak polisher [Merck, catalog number: CDUFBI001])
26. Semi-preparative high-performance liquid chromatography (HPLC) system 
equipped with an autosampler, multiple wavelength detector and a fraction 
collector (e.g., Agilent 1200 Series) and software for peak analysis
27. New Brunswick™ Innova® 42 incubator (Eppendorf, New Brunswick™, model: 
Innova® 42, catalog number: M1335-0002)
28. Sorvall LYNX 4000 Superspeed Centrifuge (Thermo Fisher Scientific, Thermo 
Scientific™, catalog number: 75006580) or an equivalent centrifuge that can be 
cooled down to 4 °C and can perform up to 6,000 x g
29. New Brunswick™ Innova® 44/44R (Eppendorf, New Brunswick™, model: 
Innova® 44/44R, catalog number: M1282-0002) or any equivalent shaker 
incubator where the temperature can be set at 37 °C and 18 °C
30. Cell density meter Ultrospec™ 10 (GE Healthcare, catalog number: 
80-2116-30), or equivalent spectrophotometer that can measure the density of 
cells in suspension at 600 nm
31. SONOPULS HD 3200 Sonifier (BANDELIN electronic, model: HD 3200) with 
VS 70 T Sonotrode (BANDELIN electronic, model: VS 70 T) or alternatively a 
French Pressure Cell (French Press) for cell lysis
32. Peristaltic pump P-1 with connectors for 5 ml HisTrap HP (GE Healthcare, 
catalog number: 18111091)
33. Tubing Connectors for Use with Peristaltic Pump P-1 (GE Healthcare, catalog 
number: 11300082)
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34. ÄKTApurifier 10 FPLC system (GE Healthcare, catalog number: 28406264)
35. Sorvall LYNX 4000 Superspeed Centrifuge (Thermo Fisher Scientific, Thermo 
Scientific™, catalog number: 75006580) or an equivalent centrifuge that can be 
cooled down to 4 °C and can perform up to 30,000 x g
36. pH meter ProLine B210 (QiS)
37. Filter holder assembly for filtration (Merck, catalog number: XX1014700 or 
Nalgene, Thermo Fisher Scientific, Thermo Scientific™, catalog number: 
DS0320-2545)
38. Diaphragm Vacuum Pumps LABOPORT® N 820 (ABM van Zijl B.V, catalog 
number: ABMK N8203FT18)
39. Mini-PROTEAN Tetra cell vertical electrophoresis system (Bio-Rad 
Laboratories, model: Mini-PROTEAN Tetra Cell, catalog number: 
1658004EDU)
40. Perfection V850 Pro scanner (Epson) for SDS-PAGE gel imaging
Software
1. ChemStation for LC, Rev. B. 03.02 (Agilent Technologies)
2. ChemStation for LC/MS, Rev. B. 04.03-SP2 (Agilent Technologies)
3. Leica LAS X SP8 (version 1.0)
4. Leica LAS AF (Lite) software (version 3.3) (available for free)
5. ImageJ software (version 1.51 n) (available for free)
6. FlowJo software (version 10.2) for FACS analysis
7. GraphPad’s Prism7 software for statistical analyses
To purchase software, please visit the respective company webpage.
Procedure
A. Generation of Benzylguanine (BG)-coupled repair template oligos
1. BG oligo coupling reaction
Notes:
i. Starting with a 5 nmol reaction results in approximately 3 
nmol BG-coupled oligo after HPLC purification. For a 
transfection of HEK293T cells in a single 24-well 2.2 pmols 
are needed.
ii. The ratio 100:1 BG-GLA-NHS: amino-modified oligo has 
been optimized to achieve maximal coupling for 81 base long 
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oligos. For shorter oligos, smaller ratios of BG-GLA-NHS: 
amino-modified oligo could be applied.
a. Dissolve 2 mg BG-GLA-NHS in 207 μl DMF. This gives a 
stock concentration of 20 mM. Syringe and needle are needed 
for the DMF, when this is packaged with a Sure/Seal™. 
Before starting the experiment, prepare a BG-GLA-NHS 
working stock solution of 3.3 mM in DMF.
b. Mix the following components in 1.5 ml Eppendorf tubes in a 
flow hood (see the following Table for amounts, this example 
is for 5 nmols reaction in the ratio 100:1 BG-GLA-NHS: 
amino-modified oligo):
Component Working Concentration Volume
BG-GLA-NHS 3.3 mM 150 μl
Oligo-NH2 100 μM 50 μl
HEPES pH 8.5 200 mM 100 μl
c. Mix the components properly by pipetting the up and down 5 
times.
d. Incubate the BG coupling reaction at 30 °C for 60 min.
PAUSE POINT: BG coupling reactions can be stored at -20 °C when 
decided not to proceed with the protocol on the same day.
2. Ethanol precipitation on BG coupling reactions
a. Add the following components to the BG coupling reaction:
Component Stock Concentration Volume
Sodium acetate 3 M 80 μl
Glycogen 20 μg 1 μl
Isopropanol 100% 1 vol
b. Vortex the BG coupling reaction briefly and store the 
Eppendorf tube(s) at -20 °C for 4-6 h or overnight (PAUSE 
POINT).
c. Spin the Eppendorf tube(s) for 15 min at 13,500 x g at 4 °C.
d. Remove the supernatant and add 500 μl 100% ethanol (-20 °C) 
to wash the pellet.
e. Spin for 10 min at 13,500 x g at 4 °C.
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f. Remove the supernatant and add 500 μl 80% ethanol (-20 °C) 
to wash the pellet.
g. Spin for 10 min at 13,500 x g at 4 °C.
h. Remove the supernatant and air dry the pellet for 10-15 min.
i. Dissolve the pellet in 200 μl RNase-free sterile water when 
proceeding with purification of the BG-coupled DNA on 
reversed phase HPLC. When using the Glen Gel-Pak cartridge 
purification method, dissolve the pellet in 1,500 μl RNase-free 
sterile water.
3. Purification of BG-coupled DNA on reversed phase HPLC
a. Dilute reaction mixture to 200 μl with RNase-free ultrapure 
H2O.
b. Determine the threshold for UV absorbance based fraction 
collection:
Inject 10 μl of the crude reaction mixture and record 
chromatogram at 260 nm. Perform purification on an Agilent 
1200 Series HPLC system (see item 26 in the equipment list) 
fitted with a Waters XBridge Oligonucleotide BEH C18 
column (10 x 50 mm, 2.5 μm) at 65 °C using a gradient of 
5%-25% methanol (Table 1) over 8 min with a flow rate of 5 
ml min-1. HPLC eluent A is 0.1 M triethylammonium acetate, 
pH 8.0 (see Recipes).
c. Estimate a suitable threshold for bulk product purification 
according to the following empirical formula:
A2 =
2 × V2 × A1
3 × V1
where,
V1= volume of test injection
V2= volume of main injection
A1= absorbance threshold suitable for test injection
A2= absorbance threshold suitable for main injection
d. Bulk product purification:
Inject residual 190 μl of the reaction mixture and collect the 
product containing fraction using the threshold estimated 
above.
e. Remove solvent under vacuum from product containing 
fractions using a centrifugal concentrator, such as Genevac 
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miVac Duo, at 35 °C and re-dissolve the purified product in 
100 μl RNase-free ultrapure H2O. A representative HPLC 
chromatogram of the separation of BG-coupled DNA from 
unreacted 5’-amino DNA is shown in Figure 2.
Note: If the lab has no access to a suitable HPLC system, the 
ethanol precipitated BG-coupled oligos can also be further 
separated from unreacted BG by using a size-exclusion based 
desalting column, such as Glen Gel-Pak 1.0. For Glen Gel-Pak 
based purification follow the manufacturer’s protocol. In our 
hands, the combination of ethanol precipitation and Glen Gel-
Pak based purification resulted in only a slightly lower 
coupling efficiency compared to the purification on reversed 
phase HPLC (Figure 3). In addition, when we functionally 
tested RNPD complexes purified with different methods in 
fluorescent HEK reporter cells, we found that the correction 
efficiencies were comparable (Figure 4).
4. Quality control of purified BG-coupled DNA by LC/MS
a. Mix 1 μl purified BG-DNA with 30 μl RNase-free ultrapure 
H2O in a 1.5 ml screw neck vial with a 200 μl insert.
b. Inject 30 μl and record absorbance at 260 nM and total ion 
chromatogram (TIC). Perform LC/MS analysis on an Agilent 
1200 Series HPLC fitted with a Waters Acquity UPLC OST 
C18 column (2.1 x 50 mm, 1.7 μm) connected to an Agilent 
6130 Series Quadrupole (or equivalent) using a gradient of 
5%-45% methanol (see Table 2) over 14 min with a flow rate 
of 0.3 ml min-1 at 65 °C. LC/MS eluent A is aqueous 0.4 M 
1,1,1,3,3,3-hexafluoro-2-propanol containing 15 mM 
triethylamine.
MS parameters (negative mode) are as follows:
i. Mass range: m/z 500-3000
ii. Capillary voltage: 3500V
iii. Drying gas flow: 13.0 L/min
iv. Drying gas temperature: 350 °C
v. Nebulizer pressure: 45 psi
B. Production of Cas9-SNAP protein
1. Expression of SpCas9-SNAP in E. coli
a. Transformation (Day 1)
Savić et al. Page 13
Bio Protoc. Author manuscript; available in PMC 2019 January 21.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
i. Add 1 ng of pNS20-SpCas9-SNAP plasmid 
(Addgene #113717) to 50 μl of chemically competent 
E. coli Rosetta™ 2 (DE3) cells.
ii. Tap gently to mix and incubate tube on ice for 30 
min.
iii. Incubate cells at 42 °C for 45 s in a heat block.
iv. Immediately place tube back on ice for 3 min.
v. Add 350 μl of room temperature sterile LB medium.
vi. Incubate at 37 °C while shaking for 60 min.
vii. Plate 100 μl of the mixture on an LB agar plate 
containing 50 μg/ml of kanamycin and 33 μg/ml of 
chloramphenicol. Use sterile glass beads or a 
Drigalski spatula for spreading the cells.
viii. Incubate LB agar plate overnight at 37 °C.
b. Preparation of media and stock solutions (Day 1)
i. Prepare 8 x 750 ml LB media in 2 L Erlenmeyer 
flasks.
ii. Prepare 1 x 100 ml LB media in a 250 ml 
Erlenmeyer flask for pre-culture.
iii. Prepare antibiotic stock solutions.
c. Start pre-culture (Day 2)
i. Add 100 μl of 50 mg/ml kanamycin stock solution 
and 33 μl of 50 mg/ml chloramphenicol stock 
solution to 100 ml of sterile LB medium prepared on 
Day 1.
ii. Pick a single colony from the LB agar plate of E. coli 
Rosetta 2 (DE3) cells transformed with P120 on Day 
1. For picking, you can use a sterile pipette tip or an 
autoclaved tooth pick.
iii. Incubate pre-culture at 37 °C overnight while 
shaking at 220 rpm. Start pre-culture in the late 
afternoon.
iv. Prepare 10 ml of IPTG stock solution.
d. Expression of SpCas9-SNAP in E. coli Rosetta™ 2 (DE3) 
(Day 3)
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i. Add 750 μl of 50 mg/ml kanamycin stock solution 
and 750 μl of 33 mg/ml chloramphenicol stock 
solution to each of the 750 ml LB media from Day 1.
ii. Inoculate each flask with 10 ml of the overnight 
preculture prepared on Day 2.
iii. Incubate the cultures at 37 °C while shaking at 110 
rpm.
iv. Check the optical density at a wavelength of 600 nm 
(OD600) of the culture every hour until it reaches 
0.6-0.8.
v. Reduce the temperature in the incubator to 18 °C.
vi. Remove a 1 ml sample of the culture and centrifuge 
for 10 min at 17,000 x g. Discard the supernatant and 
resuspend the pellet in 1x Laemmli SDS loading 
buffer according to the measured OD600, by adding 
10 μl of 1x Laemmli buffer per 0.1 absorbance (i.e., 
if OD600 is 0.7 add 70 μl of 1x Laemmli buffer). 
Store the sample at -20 °C for later analysis by SDS-
PAGE (“uninduced culture” sample).
vii. To induce the expression of SpCas9-SNAP, add 150 
μl of 1 M ITPG to each flask (0.2 mM final 
concentration).
viii. Incubate culture overnight at 18 °C (~16 h), shaking 
at 110 rpm.
ix. Prepare 100 ml of Lysis buffer, 1 L of Wash buffer 
and 1 L of Elution buffer.
e. Harvesting of bacterial culture (Day 4)
i. Before harvesting the cells, remove a 200 μl sample 
from overnight culture for SDS-PAGE analysis 
(“induced culture” sample), add 800 μl LB medium 
and determine the OD600. Centrifuge for 10 min at 
17,000 x g. Discard the supernatant and resuspend 
the pellet according to the measured OD600 (same 
procedure like with the uninduced sample as 
described in Step B1d vi). Store at -20 °C.
ii. Transfer overnight cultures from Day 3 in 1 L 
centrifuge bottles.
iii. Pellet the cells by centrifuging at 5,000 x g at 4 °C 
for 20 min.
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iv. Discard supernatant.
v. Cell pellets can be stored at -20 °C (pellets can be 
also frozen and stored after resuspension in Lysis 
buffer).
vi. Prepare buffers for Ion exchange and Size exclusion 
chromatography (500 ml of Heparin buffer A, 500 ml 
of Heparin buffer B, 1 L of SEC buffer).
2. SpCas9-SNAP purification
Purification of SpCas9-SNAP: Part I (Day 4)
a. If cell pellets were frozen after harvesting, thaw the cell pellets 
on ice.
b. Resuspend pellets in a total volume of 40 ml of Lysis buffer 
(~2.5-5 ml Lysis buffer per gram of cell pellet).
c. To lyse the cells use a sonicator with the following settings: 6 
min total time, 1 s on, 2 s off, 20% amplitude. The cell 
suspension noticeably changes color and viscosity during 
lysis.
d. Transfer the lysed cells into Oak Ridge centrifuge tubes and 
centrifuge for 45 min at 30,000 x g at 4 °C.
e. Remove a 5 μl sample of the cleared lysate for SDS-PAGE 
analysis (“clarified lysate” sample, Figure 8). Mix with 20 μl 
1x Laemmli buffer. Store at -20 °C.
f. Use a peristaltic pump to wash a 10-ml self-packed Ni-NTA 
Superflow column (or two 5 ml QIAGEN Ni-NTA Superflow 
prepacked cartridges connected in series) with 5 column 
volumes of water at a flow rate of 3 ml/min.
g. Wash the column with another 5 column volumes of Wash 
buffer.
h. Load the cleared lysate (~50 ml) onto the equilibrated column 
with a flow rate of 3 ml/min.
Note: There might be still unbound SpCas9-SNAP protein left 
in the flow-through. It can be loaded again on the Ni-NTA 
column for a second round of purification. Equilibrate the Ni-
NTA column in Wash buffer before reloading the flow-
through.
i. Remove a 5 μl sample of the flow-through for SDS-PAGE 
analysis (“flow-through” sample, Figure 8) and mix it with 20 
μl 1x Laemmli buffer. Store at -20 °C.
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j. Wash the pumps of the Äkta FPLC system with Wash buffer 
(pump A) and Elution buffer (pump B) and flush the flow-path 
of the system with Wash buffer until the absorbance signal 
(280 nm wavelength, A280) in the UV detector reaches a stable 
baseline.
k. Connect the loaded Ni-NTA column to the Äkta FPLC and 
wash the column with Wash buffer with a flow rate of 3 
ml/min until A280 reaches baseline level (Figure 5).
l. Elute the protein with 50% Elution buffer and collect in 1.8 ml 
fractions in a 96-well 2 ml deep-well block, or in tubes with 
appropriate capacity (Figure 5).
m. Pool the peak fractions in a clean 50 ml tube and determine 
the concentration by measuring the absorbance at 280 nm 
using a NanoDrop UV-VIS spectrophotometer. The extinction 
coefficient of His6-MBP-TEV-SpCas9-SNAP is 1416140 M-1 
cm-1.
n. Remove a 5 μl sample of the pooled fractions for SDS-PAGE 
analysis (“Ni-NTA elution” sample, Figure 8) and mix it with 
20 μl 1x Laemmli buffer. Store at -20 °C.
o. Add 1 mg of recombinant, His-tagged TEV per 50 mg of Cas9 
SNAP (as determined from absorbance measurement).
p. Incubate overnight at 4 °C.
Purification of Cas9 SNAP: Part II (Day 5)
a. Remove a 5 μl sample of the overnight TEV cleavage reaction 
for SDS-PAGE analysis (“TEV cleavage” sample, Figure 8) 
and mix it with 20 μl 1x Laemmli buffer. Store at -20 °C.
b. Heat the collected samples for SDS-PAGE analysis for 5 min 
at 95 °C.
c. Load 3 μl on a 12% SDS PAGE gel with 15 wells to check if 
cleavage is complete.
d. Connect a 5 ml Heparin FF column to a peristaltic pump and 
wash with at least 5 column volumes of water at a flow rate of 
3 ml/min.
e. Equilibrate the column with at least 5 column volumes of 
Heparin buffer A.
f. Load the overnight cleavage reaction onto the column and 
collect the flow-through in a clean 50 ml tube.
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g. Remove a 5 μl sample of the flow-through for SDS-PAGE 
analysis (“Heparin flow-through” sample, Figure 8) and mix 
it with 20 μl 1x Laemmli buffer. Store at -20 °C.
h. Wash the pumps of the Äkta FPLC with Heparin buffer A and 
Heparin buffer B and flush the flow path of the system with 
Heparin buffer A until it reaches a stable baseline at the 
absorbance of 280 nm.
i. Connect the loaded Heparin FF column to the Äkta FPLC 
system and wash the column with Heparin buffer A at a flow 
rate of 3 ml/min until the A280 signal reaches a steady baseline 
(Figure 6).
j. Elute with a linear gradient to 50% Heparin buffer B over 20 
column volumes (100 ml).
k. Collect eluted protein in 1.8 ml fractions in a 96-well 2 ml 
deep-well block, or in tubes with appropriate capacity (Figure 
6).
l. Pool the peak fractions containing SpCas9-SNAP (Figure 6).
m. Remove a 20 μl sample of the pooled fractions for SDS-PAGE 
analysis (“Heparin peak” sample, Figure 8) and mix it with 5 
μl 5x Laemmli buffer. Store at -20 °C.
n. Transfer the pooled fractions to an Amicon Ultra-15 
Centrifugal Filter Unit (MWCO of 100 kDa). Centrifuge the 
sample at 4,500 x g at 4 °C and concentrate to a final volume 
of < 5 ml. Mix the concentrate periodically throughout the 
concentration procedure by gently pipetting the solution up 
and down.
o. Transfer concentrated sample into a 15 ml tube and centrifuge 
for 5 min at 4,500 x g at 4 °C to remove any precipitated 
material.
p. In the meantime, equilibrate a HiLoad 16/600 Superdex 200 
pg with 1 column volume of SEC buffer on the Äkta FPLC at 
a flow rate of 1 ml/min.
q. Prepare a 5 ml injection loop by washing with 15 ml of SEC 
buffer on the Äkta FPLC. Flush the injection port with 10 ml 
of SEC buffer using a 10 ml syringe.
r. Load the concentrated sample on the HiLoad 16/600 Superdex 
200 pg via the 5 ml injection loop at a flow rate of 1 ml/min. 
Elute with SEC buffer at a flow rate of 1 ml/min (Figure 7).
s. Collect elution in 1.8 ml fractions in a 96-well 2 ml deep-well 
block, or in tubes with appropriate capacity (Figure 7).
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t. Pool the peak fractions and determine the concentration by 
measuring the absorbance at 280 nm using the NanoDrop UV-
VIS spectrophotometer. Remove a 20 μl sample of the pooled 
fractions for SDS-PAGE analysis (“SEC peak” sample, Figure 
8) and mix it with 5 μl 5x Laemmli Buffer. Store at -20 °C.
u. Concentrate the SpCas9-SNAP protein to the required 
concentration (~1 mg/ml) by using an Amicon Ultra-15 
Centrifugal Filter Unit (MWCO of 100 kDa). SpCas9-SNAP 
can be concentrated up to 10-20 mg/ml as long as the SEC 
buffer contains at least 500 mM KCl.
v. Prepare 50 μl aliquots of purified SpCas9-SNAP protein, 
freeze in liquid nitrogen and store at -80 °C.
C. Production of sgRNA
Guide RNAs can be produced via in vitro transcription from a template DNA 
(see protocol below), or purchased from various sources (e.g., Integrated DNA 
Technologies).
1. sgRNA production
a. Order IVT primers that generate the DNA template when 
annealed:
i. sgRNA specific forward primer with T7 promoter: 
GAAATTAATACGACTCACTATA(GGN18-20)GTT
TTAGAGCTAGAAATAGC
Note: An example from the Savic et al. publication–
sgRNASpCas9 (mutRFP) for: 
GAAATTAATACGACTCACTATAGGTGGCTACC
AGCTTCATGCTGTTTTAGAGCTAGAAATAGC 
(Savic et al., 2018).
ii. SpCas9 common reverse primer containing the 
sequence of the sgRNA scaffold: 
AAAAGCACCGACTCGGTGCCACTTTTTCAAG
TTGATAACGGACTAGCCTTATTTTAACTTGCTA
TTTCTAGCTCTAAAAC
b. Perform the PCR with Phusion polymerase using a Thermal 
cycler Reaction setup:
Component Final Concentration 100 μl Reaction
sgRNA specific forward 10 μM 5 μl
sgRNA common reverse 10 μM 5 μl
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Component Final Concentration 100 μl Reaction
HF buffer 5x 20 μl
dNTPs 2 mM 20 μl
Phusion polymerase 1 U 1 μl
ddH2O 49 μl
Thermocycling conditions:
Step Temp. Time
Initial Denaturation 98 °C 30 s
35 Cycles
98 °C 10 s
60 °C 30 s
72 °C 15 s
Final Extension 72 °C 10 min
Hold 4 °C ∞
c. Purify the DNA template using QIAquick purification kit, 
according to the manufacturer’s protocol and elute in 50 μl 
DEPC-treated water. Measure the eluted DNA concentration 
on a NanoDrop spectrophotometer.
d. Run 500 ng of the purified PCR products mixed with 5 
volumes of 6x loading dye on a 2% agarose gel containing 1x 
GelRed Nucleic Acid Stain. Separate bands by electrophoresis 
in 1x TBE buffer at 100 V for 1 h using Horizontal 
Electrophoresis System. Image using a Gel imaging System to 
confirm the concentration and the correct amplicon size.
Important: From here on, work RNase free! 
e. In vitro transcribe the template DNA using the T7 RNA 
polymerase to obtain the guide RNA.
Component Final Concentration 30 μl Reaction
10x Transcription buffer 2x 6 μl
25 mM NTP (A,U,C,G) mix 2 mM 2.4 μl
T7 RNA polymerase 20 U/μl 2 μl
template DNA 500 ng X μl
DEPC-treated H2O to 30 μl
Incubate reaction overnight at 37 °C in the Thermal Cycler.
2. sgRNA purification
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a. Purify the sgRNA by DNase I treatment followed by ethanol 
precipitation:
i. Add 1 μl DNase I and incubate for 15 min at 37 °C in 
the Thermal Cycler.
ii. Add DEPC-treated water up to 100 μl.
iii. Add 10 μl 5 M Ammonium acetate and 330 μl 100% 
ethanol and incubate overnight at -20 °C.
iv. Add 1 μl Glycogen (20 μg), vortex and centrifuge at 
17,000 x g for 15 min at 4 °C using Microlitre 
Centrifuge.
v. Wash the pellet with 500 μl 75% ethanol and 
centrifuge at 17,000 x g for 15 min at 4 °C using 
Microlitre Centrifuge.
vi. Dissolve the pellet in 20-30 μl DEPC-treated water.
b. Purify the sgRNAs further using RNA Clean and 
Concentrators, according to the manufacturer’s protocol. 
Measure the eluted RNA concentration on NanoDrop 
spectrophotometer. Store the RNA at -80 °C.
3. sgRNA control on a denaturing MOPS gel
a. Control the sgRNA on a denaturing 2% MOPS gel:
i. Prepare the gel
Heat 2 g agarose in 80 ml double distilled and 
deionized water using a microwave oven until 
dissolved, and then cool to 60 °C. Add 10 ml 10x 
MOPS running buffer, and 10 ml 37% formaldehyde 
(12.3 M), pre-warmed to 60 °C using a water bath. 
Mix and pour the gel using a comb that will form 
wells large enough to accommodate at least 25 μl. 
Let the gel settle for 30 min. Assemble the gel in the 
tank, and add enough 1x MOPS running buffer to 
cover the gel by a few millimeters. Remove the 
comb.
Note: Prewash the chamber, tray, and comb with 
soapy water/tween/SDS, wipe with RNase AWAY, 
and remove the leftover RNase AWAY with a paper 
tissue. Use autoclaved or UV-treated Erlenmeyer 
flask.
Warning: Formaldehyde is toxic through skin contact 
and inhalation of vapors. Manipulations involving 
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formaldehyde should be done in a chemical fume 
hood.
ii. Prepare RNA samples and ladder
1) Add 3 volumes of Formaldehyde Load Dye 
to 1 μg (500 ng/u) sgRNA. Adjust total 
volume to 10 μl with DEPC-treated water. 
Use 2 μg of Low Range ssRNA Ladder.
2) Heat denature samples at 65 °C for 15 min 
using a Thermoshaker.
3) Briefly spin down samples in a 
microcentrifuge and place on ice.
iii. RNA electrophoresis
Load the gel and run at 5-6 V/cm (approx. 80 V) 
until the bromophenol blue (the faster-migrating dye) 
has migrated at least 2-3 cm into the gel, then raise to 
120 V and let run as far as 2/3 the length of the gel.
iv. Stain the RNA gel using Sybr Gold
1) Dissolve 15 μl of Sybr Gold (10,000x) in 
150 ml TE buffer pH 8.0.
2) Incubate for 45 min, shaking at room 
temperature. Wash 1 x 5 min in TE buffer 
followed by 1 x 5-min wash in double 
distilled and deionized water.
Note: Protect the gel from the light during 
incubation.
v. Image on ChemiDoc imaging System to confirm the 
concentration and the RNA quality.
Note: An example of denaturing RNA gel with in 
vitro transcribed sgRNAs can be found in Figure 3–
figure supplement 1g from Savic et al. 2018.
D. Cell culturing
1. Culture HEK293T line
Notes:
i. Change cell culture medium (for HEK293T medium, see 
Recipes) every other day.
ii. Passage cells before they become fully confluent, 
approximately every 4 days.
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iii. Cells grow at 37 °C in a humidified 5% CO2 environment.
a. Aspirate the medium from dish.
b. Add 1 ml of TrypLE Express per 10 cm (for a 10 cm dish).
c. Place the plate in the 37 °C incubator for 5 min.
d. Once the cells detach, add 9 ml of DMEM medium and 
transfer the cells to a 15 ml conical tube.
e. Centrifuge at 250 x g for 5 min at 4 °C.
f. Aspirate the medium from the conical tube.
g. Add 10 ml of fresh DMEM medium and split cells at a 
1:10-1:15 dilution factor on to a new 10 cm dish and add 
enough additional medium to each plate for 10 ml total.
2. Culture K562 line (suspension)
Notes:
i. Change cell culture medium (for K562 medium, see Recipes) 
every other day.
ii. Passage cells before they become fully confluent, 
approximately every 4 days.
iii. Cells grow at 37 °C in a humidified 5% CO2 environment.
a. Collect the K562 cells from the dish in a 15 ml conical tube.
b. Centrifuge at 250 x g for 5 min at 4 °C.
c. Aspirate the medium from the tube.
d. Add 10 ml of fresh RPMI medium and split cells at a 1:5-1:10 
dilution factor on to a new 10 cm dish and add enough 
additional medium to each plate for 10 ml total.
3. Culture mouse embryonic stem cell line
Notes:
i. Change cell culture medium (for mESC proliferative growth 
medium, see Recipes) daily.
ii. Passage cells every 2-3 days depending upon the growth rate 
of cells. The optimal condition is to maintain cells at 
approximately 80% confluency on Day 2 or 3.
iii. Cells grow at 37 °C in a humidified 8% CO2 environment.
iv. mECS grow on 0.2% gelatin-coated flasks/plates in absence of 
feeder cells.
a. Aspirate the medium from the T75 flask.
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b. Rinse the T75 flask or dish with PBS pH 7.4 (1x) without 
CaCl2 and MgCl2.
c. Add 1 ml 0.05 % Trypsin containing EDTA to the flask.
d. Place the flask in the 37 °C incubator for 5 min.
e. Once cells begin to dissociate from the flask, transfer the 
detached cell aggregates to a 15 ml conical tube containing 5 
ml mESC DMEM growth medium.
f. Rinse the flask with an additional 3 ml of DMEM growth 
medium to collect any remaining aggregates. Add the rinse to 
the conical tube that contains the cells.
g. Centrifuge the conical tube at 250 x g for 2 min at room 
temperature.
h. Aspirate the medium from the conical tube and add the desired 
amount of growth medium. Split the cells at a 1:4 to 1:10 
dilution factor into a new flask or dish and add enough 
additional growth medium to each flask or plate.
E. Covalent binding of Cas9-SNAP protein and BG-coupled oligonucleotide
Complex the BG-coupled repair oligo templates with Cas9-SNAP proteins 
directly before performing the transfection.
1. Thaw the SpCas9-SNAP protein on wet ice.
Note: Very small samples such as 10 μl aliquots can be thawed by 
holding the tube in your hand.
2. Once thawed, gently mix the sample using a micropipettor with a 
polypropylene tip to make sure the solution is homogeneous. Be careful 
not to introduce bubbles into the solution. When necessary, dilute the 
protein in Protein buffer.
3. Mix 2.2 pmols BG-coupled oligos together with 2.2 pmols SpCas9-
SNAP protein in 1.5 ml Safe-Lock microcentrifuge tubes.
4. Mix by flicking the microcentrifuge tubes.
5. Briefly spin down samples in a microcentrifuge.
6. Incubate for 60 min at 30 °C using Thermoshaker.
7. Briefly spin down samples in a microcentrifuge.
8. Place the sample on ice until used for cell transfection.
Note: An example of silver-stained SDS-PAGE gels showing band shifts that 
confirm covalent linkage of Cas9-SNAP proteins to BG-coupled oligos can be 
found in Figures 3e and 3f from Savic et al., 2018.
F. Transfecting cell lines with RNPD complexes
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1. Seeding HEK293T cells
One day prior to transfection (24 h): Seed HEK293T cells at a density 
of 120,000-140,000 cells per well in 24-well plates.
a. Aspirate the medium from dish.
b. Add 1 ml of TrypLE Express (for a 10 cm dish).
c. Place in a 37 °C incubator with 5% CO2 environment for 5 
min.
d. Once the cells detach, add 9 ml of DMEM medium and 
transfer the cells to a 15 ml conical tube.
e. Pipette up and down several times with 5 ml Serological 
pipette to ensure single cell suspension.
f. Perform a cell count using a hemocytometer or automated cell 
counter.
g. Dilute the cells with DMEM medium at the desired final 
concentration of 120,000-140,000 cells/well.
2. Seeding mES cells
One day prior to transfection (24 h): Seed mES cells at a density of 
180,000-190,000 cells per well in 6-well plates.
a. Aspirate the medium from a flask or dish.
b. Rinse the T75 flask or dish with PBS pH 7.4 (1x) without 
CaCl2 and MgCl2.
c. Add 1 ml 0.05% Trypsin containing EDTA to the flask or dish.
d. Place the flask in the 37 °C incubator with 5% CO2 
environment for 5 min.
e. Once cells begin to dissociate from the flask, transfer the 
detached cell aggregates to a 15 ml conical tube containing 5 
ml mESC growth medium.
f. Rinse the flask with an additional 3 ml of growth medium to 
collect any remaining aggregates. Add the rinse to the conical 
tube containing the cells.
g. Perform cell count using a hemocytometer or automated cell 
counter.
h. Dilute the cells with DMEM growth medium without PenStrep 
at the desired final concentration of 180,000-190,000 cells/
well.
3. Seeding K562 cells
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On the day of transfection: K562 cells (suspension culture) can be 
distributed 6 h prior to transfection in 24-well plates at a density of 
220,000-240,000 cells per well.
a. Collect the K562 cells from the dish in a 15 ml conical tube.
b. Centrifuge at 250 x g for 5 min at 4 °C.
c. Aspirate the medium from the tube.
d. Add fresh RPMI medium and pipette up and down several 
times with 5 ml Serological pipette to ensure a homogeneous 
cell suspension.
e. Perform cell count using a hemocytometer or automated cell 
counter. Dilute the cells with RPMI medium at the desired 
final concentration of 120,000-140,000 cells/well.
4. Preparation of transfection reactions
Prepare transfection reactions by mixing following components in a 
laminar flow hood (see Table 3 for amounts, this example is for 24-well 
plate format):
a. 1.5 ml Eppendorf Tube A: Add selected RNP complex (2.2 
pmols), and sgRNA (3.88 pmols) to Opti-MEM. Total volume 
in reaction Tube A should be 50 μl after adding components.
b. 1.5 ml Eppendorf Tube B: Add 3 μl Lipofectamine 2000 to the 
47 μl Opti-MEM. Total volume in the reaction Tube B should 
be 50 μl.
c. Briefly vortex Tube A and B, and spin down samples in a 
microcentrifuge.
d. Incubate for 5 min at room temperature.
e. Add the content of Eppendorf Tube B to Eppendorf Tube A, 
briefly vortex and spin the content down in a microcentrifuge.
f. Incubate the complexes at room temperature for 15 min, to 
allow lipid particle formation.
g. Add the transfection mixture to the desired wells, by slowly 
dropping the mixture on the medium.
h. Gently mix the media via back and forth motion.
Note: The medium of the mES transfected cells should be 
replaced to mES culture medium with Pen-Strep 8 h post-
transfection.
i. Incubate at 37 °C with 5% CO2 environment for 24 h.
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j. Next day (post-transfection), HEK293T and K562 cells can be 
transferred to 10 cm dish for further expansion of the 
transfected cells.
k. The mES cells can be collected after 48 h post transfection for 
extracting genomic DNA.
l. At Day 5 post-transfection, HEK293T and K562 cells can be 
analyzed by different methods. When a reporter-line is used, 
the correction and indel formation events can be visualized by 
fluorescence imaging and quantified by FACS. In case no 
reporter line used, cells can be collected for DNA extraction 
and analysis via next-generation sequencing (NGS).
G. Correction efficiency analysis
The protocols described here allow to assess the correction rates of the RNPD 
system in the cell line of interest. The protocols are designed for HEK293T cells, 
and would have to be adapted for the cell line of interest.
1. Microscopy imaging
As mentioned above, when a fluorescent reporter cell line is used, 
correction and indel formation events can be visualized by either 
fluorescence imaging or flow cytometry. One day post-transfection, the 
HEK reporter cell line can be transferred to Poly-L-lysine coated glass 
chamber slides and can be analyzed 5-7 days post-transfection.
Conformation and visualization by microscope imaging can be achieved 
as followed:
a. A few hours before transferring the transfected cells, coat the 
glass chamber slides with Poly-L-lysine. Pour a few hundred 
microliters of 0.2% Poly-L-lysine solution on the bottom of 
the chamber slides, distribute homogeneously (the entire 
surface must be covered, e.g., 150 μl for 8-well chamber 
slide), incubate for minimum 1 h at 37 °C and finally remove 
the leftover Poly-L-lysine solution that is on the chamber 
slides.
Note: Store the chamber slides until use in a 37 °C incubator 
when using them on the same day or else store the chamber 
slides at 4 °C.
b. Aspirate the medium of the HEK293T cells that got 
transfected the day before.
c. Add 100 μl of TrypLE Express to each well (in case of 24-well 
plate).
d. Pipette up and down several times with a P200 pipet to ensure 
single cell suspension.
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e. Add 240 μl pre-warmed DMEM medium (HEK293T cells) to 
the coated chamber slides.
f. Take 10 μl of the trypsinized HEK293T suspension and add 
this to the coated chamber slide. Let the HEK293T cells grow 
until they reach a confluency of 80%-90%. This will be 
probably around Days 5-7 post-transfection.
g. Prior to the image session, add Hoechst 33342 to the cell 
culture medium to a final concentration of 0.1 μg/ml.
h. Incubate the cells for 10 min at 37 °C with 5% CO2 
environment.
i. Start imaging session.
2. Flow cytometry analysis
Depending on the type of experiment, the best time point for flow 
cytometry analysis should be determined by the experimenter. In this 
protocol, we analyze HEK293T reporter cells at 5 days post-
transfection. Important note when performing flow cytometry: Make 
use of proper controls for setting up your gating.
Quantification of correction and indel formation events by flow 
cytometry analysis can be achieved as followed:
a. Aspirate the medium of dishes.
b. Add 1 ml of TrypLE Express per 10 cm dish.
c. Incubate for 3 min at 37 °C.
d. Once the cells detach, add 4 ml of DMEM medium and 
transfer the cells to a 15 ml conical tube.
e. Centrifuge at 250 x g for 5 min at 4 °C.
f. Aspirate the supernatant.
g. Add 1 ml FACS buffer with or without Sytox Red to the cell 
pellet and pipette up and down several times with P1000 pipet 
to ensure single cell suspension. Sytox Red can be added for 
excluding dead cells from the populations.
h. Transfer the cell suspension to 5 ml test tubes with cell 
strainer cap.
i. Place samples on ice until starting with the flow cytometry 
analysis on the BD LSR Fortessa cell analyzer.
3. Next Generation Sequencing (NGS)
Savić et al. Page 28
Bio Protoc. Author manuscript; available in PMC 2019 January 21.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
For the library preparation, collected cell pellets should be extracted by 
using for example a DNeasy Blood and Tissue kit, according to the 
manufacturer’s instructions. Preparation of the library:
a. PCR to amplify the target region
i. For each 50 μl reaction mix, combine the following 
in 0.2 ml tubes:
Component Volume per 
50 μl RXN
Final concentration
NEBNext HF 2x PCR 
Master Mix
25 μl 1x
10 μM forward primer 2.5 μl 0.5 μM
10 μM reverse primer 2.5 μl 0.5 μM
Template DNA 500 ng 500 ng
Nuclease-free water To 50 μl
ii. Gently mix the reaction and briefly spin down 
content in a microcentrifuge.
iii. PCR cycling conditions used in this protocol:
Step Temp. Time Cycles
Initial Denaturation 98 °C 3 min 1
Denaturation 95 °C 15 s
27Annealing 65 °C 15 s
Extension 72 °C 30 s
Final Extension 72 °C 5 min 1
Hold 4 °C ∞ 1
Note: Annealing temperatures should be optimized 
for each primer set to ensure that a single amplicon 
will be produced.
iv. Run 10 μl of the PCR products on agarose gel (2%) 
to confirm correct amplicon size.
v. Purify PCR amplicons by solid phase reversible 
immobilization (SPRI) bead cleanup using 
Agencourt AMPure XP reagent, according to the 
manufacturer’s protocol.
vi. Run 5 μl of the purified samples on agarose gel (2%) 
to confirm the purification step succeeded.
b. Generation of pooled sequencing libraries
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For generating the libraries, order Index Adaptor Sequences 
for the second amplification step. In this protocol, TruSeq 
Index Adaptor Sequences were used from Illumina (see 
Publication Savic et al., 2018).
i. For each 50 μl reaction mix, combine the following 
in 0.2 ml tubes:
Component Volume per 
50 μl RXN
Final concentration
NEBNext HF 2x PCR 
Master Mix
25 μl 1x
Illumina Adapter primer 
forward
2.5 μl 0.5 μM
Illumina Adapter primer 
reverse
2.5 μl 0.5 μM
Template DNA X μl 30 ng
Nuclease-free water To 50 μl
ii. Gently mix the reaction and briefly spin down 
content in a microcentrifuge.
iii. PCR cycling conditions used were as follows in this 
protocol:
Step Temp. Time Cycles
Initial Denaturation 98 °C 3 min 1
Denaturation 95 °C 15 s
6Annealing 69 °C 15 s
Extension 72 °C 30 s
Final Extension 72 °C 5 min 1
Hold 4 °C ∞ 1
iv. Purify the PCR products (PCR amplicons with 
adaptors) by solid phase reversible immobilization 
(SPRI) bead cleanup using Agencourt AMPure XP 
reagent, according to the manufacturer’s protocol.
v. Run 5 μl of the purified samples on an agarose gel 
(2%) to confirm the purification step succeeded and 
that the adaptors are added. Additional tip: run one 
PCR product from the first PCR along the PCR 
samples of the second PCR on the agarose gel. This 
will show a clear difference when the Index Adapters 
are successfully added to the PCR amplicons.
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Note: Before sequencing the libraries, it is 
recommended to perform a quality check on, e.g., 
Agilent 2200 TapeStation system.
Data analysis
Correction efficiencies in HEK293T fluorescent reporter cells are available in Savic et al., 
2018. For obtaining correction rates in other cell types the here described protocols would 
have to be adapted.
A. Flow cytometry
1. Example gating strategy
a. Forward versus side scatter (FSC-A vs. SSC-A) gating should 
be used to identify cells of interest.
b. Doublets should be excluded using the forward scatter height 
versus forward scatter area density plot (FSC-H vs. FSC-A).
c. Live cells should be gated based on Sytox-Red-negative 
staining.
d. Live-gated cells should be further used to quantify the 
percentage of eGFP negative and turboRFP positive 
populations, in this example.
2. Correction efficiency calculation
Correction efficiency (percentage of corrections in edited cells):
100
× eGFP/turboRFP double positive population(eGFP/turboRFP double negative population + eGFP/turboRFP double positive population)
B. NGS
The Scripts for mapping sequencing data, counting mutations and generating 
plots are available at https://github.com/HLindsay/Savic_CRISPR_HDR.
Correction efficiency calculation:
Percentage of edited alleles is calculated as:
100 × Edited readsTotal reads (excluding non‐linear alignments)
Correction efficiency is
100 × Perfectly correctedEdited reads
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Recipes
1. HEPES 200 mM pH 8.5
Dissolve 4.77 g of HEPES in 75 ml of dH2O
Adjust to desired pH using 10 M NaOH
Fill to final volume of 100 ml with dH2O
Autoclave and store at 4 °C
2. HEK293T medium
Dulbecco modified Eagle’s medium (high glucose) with GlutaMAX™ (DMEM), 
supplemented with 1% Pen-Strep and 10% FBS
Store at 4 °C
3. K562 medium
RPMI 1640 Medium with GlutaMAX™, supplemented with 1% Pen-Strep and 
10% FBS
Store at 4 °C
4. mESC proliferative growth medium
Dulbecco’s modified Eagle media (DMEM) (Sigma) supplemented with 15% 
FBS, 100 U/ml LIF, 0.1 mM 2-β-mercaptoethanol and 1% Pen-Strep
5. Gelatin solution 0.2% (w/v) (500 ml)
Dilute 1 g of gelatin from porcine skin with 500 ml of autoclaved water
Mix well and then autoclave the solution
Store at 4 °C for 1 week
6. Poly-L-lysine solution 0.2%
Prepare a stock solution by dissolving 100 mg poly-L-lysine in 100 ml water and 
filter sterilize through a 0.22-μm filter
7. FACS buffer
PBS supplemented with 1% FBS and 5 mM EDTA
8. EDTA buffer 0.5 M pH 8.0
Dissolve 93.06 g of EDTA in 400 ml of dH2O
Adjust to desired pH using 10 M NaOH or solid NaOH pellets
Fill to final volume of 500 ml with dH2O
Filter the solution through a 0.5 μm filter
Autoclave and store at room temperature
9. Protein buffer
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20 mM HEPES and 500 mM KCl, pH 7.5
10. KCl buffer 500 mM
Dissolve 1864 g of KCl in 500 ml dH2O
11. 3-(N-morpholino) propanesulfonic acid (MOPS) 10x running buffer
Dissolve 42 g of MOPS, 8.2 g of sodium acetate, 3.72 g EDTA in 1 L dH2O, pH 
7.0
Filter sterilize or autoclave
Store at room temperature protected from light
12. Tris-borate-EDTA (TBE) 10x buffer
Dissolve 108 g Tris base (121 g/mol), and 55 g Boric acid (61.8 g/mol)
Add 40 ml of 0.5 M EDTA (pH 8.0)
Adjust final volume to 1 L with double distilled and deionized water
Store at room temperature
13. Tris buffer 1 M
Dissolve 60.57 g Tris (hydroxymethyl) aminomethane (121.4 g/mol) in 0.5 L 
dH2O
Adjust pH to 8.0 using HCl
14. TE buffer pH 8.0
10 mM Tris, bring to pH 8.0 with HCl, 1 mM EDTA
To sterilize, autoclave the solution on a liquid cycle
Store at room temperature
15. HPLC eluent A
0.1 M triethylammonium acetate in RNase-free ultrapure H2O, pH 8.0
50.5 g triethylamine, 30 g acetic acid, add RNase-free ultrapure H2O to 5 L
Adjust pH to 8.0 using triethylamine and acetic acid
Filter sterilize
16. LC/MS eluent A
0.4 M 1,1,1,3,3,3-hexafluoro-2-propanol, 15 mM triethylamine
Dissolve 67.2 g 1,1,1,3,3,3-hexafluoro-2-propanol, 1.5 g triethylamine, in 1 L 
RNase-free ultrapure H2O
Filter sterilize
17. Chloramphenicol 1,000x (34 mg/ml stock)
Dissolve 0.34 g chloramphenicol in 10 ml of 100% ethanol
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Filter sterilize through a 0.22-μm filter
Store at -20 °C
18. Kanamycin 1,000x (50 mg/ml stock)
Dissolve 0.5 g kanamycin sulfate in 10 ml of sterile water
Filter sterilize through a 0.22-μm filter
Store at -20 °C
19. IPTG 1 M (IsoPropyl-1-Thio-β-D-Galactopyranoside)
Dissolve 2.38 g IPTG in 10 ml of sterile water
Filter sterilize through a 0.22-μm filter
Store at -20 °C
20. NaCl 5 M
Dissolve 292.2 g NaCl in 1 L of double distilled and deionized water
Filter sterilize through a 0.22-μm filter
21. DTT 1 M (Dithiothreitol)
Dissolve 1.54 g DTT in 10 ml of double distilled and deionized water
Filter sterilize through a 0.22-μm filter
Store at -20 °C
22. Imidazole 2.5 M pH 8.0
Dissolve 170.19 g Imidazole in 750 ml of dH2O
Adjust to desired pH using 10 M NaOH
Fill to final volume of 1 L with dH2O
Filter sterilize through a 0.22-μm filter
23. HEPES 1 M pH 7.5
Dissolve 238.3 g of HEPES in 750 ml of dH2O
Adjust to desired pH using 10 M NaOH
Fill to final volume of 1 L with dH2O
Filter sterilize through a 0.22-μm filter
24. Protease inhibitor (1:1,000)
Dissolve 5 mg Pepstatin A, 500 mg AEBSF Hydrochloride in 50 ml 100% EtOH
25. KCl 4 M
Dissolve 298.2 g KCl in 1 L of dH2O
Filter sterilize through a 0.22-μm filter
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26. Tris buffer 1 M pH 6.8
Dissolve 6.06 g Tris (hydroxymethyl) aminomethane (121.4 g/mol) in 40 ml 
dH2O
Adjust pH to 6.8 using HCl
Fill to final volume of 1 L with dH2O
Filter sterilize through a 0.22-μm filter
27. Lysis buffer
2 ml Tris pH 8.0 (20 mM)
10 ml NaCl (500 mM)
0.2 ml Imidazole pH 8.0 (5 mM)
Protease inhibitor (1:1,000)
Fill to final volume of 100 ml with dH2O
Filter sterilize through a 0.22-μm filter
28. Wash buffer
20 ml Tris pH 8.0 (20 mM)
100 ml NaCl (500 mM)
2 ml Imidazole pH 8.0 (5 mM)
Fill to final volume of 1 L with dH2O
Filter sterilize through a 0.22-μm filter
29. Elution buffer
20 ml Tris pH 8.0 (20 mM)
50 ml NaCl (250 mM)
80 ml Imidazole pH 8.0 (200mM)
Fill to final volume of 1 L with dH2O
Filter sterilize through a 0.22-μm filter
30. Heparin buffer A
10 ml Hepes pH 7.5 (20 mM)
12.5 ml KCl (100 mM)
Fill to final volume of 500 ml with dH2O
Filter sterilize through a 0.22-μm filter
31. Heparin buffer B
10 ml HEPES pH 7.5 (20 mM)
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250 ml KCl (2 M)
Fill to final volume of 500 ml with dH2O
Filter sterilize through a 0.22-μm filter
32. SEC buffer
20 ml HEPES pH 7.5 (20 mM)
125 ml KCl (250 mM)
Fill to final volume of 1 L with dH2O
Filter sterilize through a 0.22-μm filter
33. 1x Laemmli buffer
Dilute 100 μl of 5x Laemmli Buffer with 400 μl of dH2O
34. 5x Laemmli buffer
2.25 ml Tris pH 6.8
5 ml glycerol (100%)
0.5 g SDS
5 mg Bromophenol blue
2.5ml DTT
Final volume will be 10 ml
Filter sterilize through a 0.22-μm filter
Store at -20 °C
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Figure 1. Schematic overview of the workflow of the protocol
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Figure 2. Representative chromatogram of the separation of unreacted DNA from 5’-BG-linked 
DNA.
5’-BG-DNA was purified using a gradient of 5%-25% methanol over 8 min. BG conjugation 
was performed under non-optimized conditions.
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Figure 3. LC/MS analysis of BG-coupled and uncoupled DNA after different methods of 
purification.
A. Uncoupled RFP DNA repair templates after HPLC purification (M = 20516.4). B. BG-
coupled RFP repair templates after HPLC purification (M = 20882.8). C. BG-coupled repair 
templates after desalting on Glen Gel-Pak cartridge only. D. BG-coupled repair templates 
after ethanol precipitation only. E. BG-coupled repair templates after ethanol precipitation 
followed by Gel-Pak cartridge purification. BG conjugation was performed under optimized 
conditions for quantitative coupling.
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Figure 4. Correction efficiency of RNPD systems with differently purified BG-coupled DNA.
Results show that repair oligos can also be purified from excess BG using Gel-Pak cartridge 
purification in combination with EtOH purification. FACS analysis of the fluorescent 
reporter cells transfected with different RNPD systems: Non-treated, no oligo, uncoupled 
RFP oligo after HPLC purification, coupled RFP oligo after HPLC purification, coupled 
RFP oligo after desalting on Glen Gel-Pak cartridge only, coupled RFP oligo after ethanol 
precipitation only, coupled RFP oligo after ethanol precipitation followed by Gel-Pak 
cartridge purification.
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Figure 5. Representative chromatogram of Cas9 SNAP purified by HisTrap HP (10 ml) affinity 
purification.
Blue line denotes absorbance signal at 280 nm (A280), green line denotes the concentration 
of the Elution buffer, and the fractions are indicated with red tick marks. The blue shaded 
area indicates fractions collected for dialysis and subsequent purification steps.
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Figure 6. Representative chromatogram of Cas9 SNAP purified by Heparin FF (5 ml) affinity 
purification.
Blue line denotes absorbance signal at 280 nm (A280), red line denotes absorbance signal at 
260 nm (A260), green line denotes concentration of the Elution Buffer. Fractions are 
indicated with red tick marks. The blue shaded area indicates fractions collected for 
subsequent purification steps.
Savić et al. Page 43
Bio Protoc. Author manuscript; available in PMC 2019 January 21.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
Figure 7. Representative chromatogram of Cas9 SNAP resolved on a HiLoad 16/600 Superdex 
200 pg size-exclusion column.
Blue line denotes absorbance signal at 280 nm (A280), red line denotes absorbance signal at 
260 nm (A260), and fractions are indicated with red tick marks. The blue shaded area 
indicates fractions pooled for final concentration.
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Figure 8. Representative analysis of SpCas9-SNAP fractions on a 10% SDS-PAGE gel.
M: PageRuler Plus Prestained Protein Ladder. Marker band sizes are indicated in kDa. The 
gel is stained with Coomassie Brilliant Blue.
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Table 1
Gradient for HPLC purification
Time (min) % HPLC eluent A % Methanol
0 95 5
8.0 75 25
8.5 5 95
9.0 5 95
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Table 2
Gradient for LC/MS analysis
Time (min) % LC/MS eluent A % Methanol
0 95 5
14.0 55 45
14.5 5 95
15.0 5 95
Bio Protoc. Author manuscript; available in PMC 2019 January 21.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
Savić et al. Page 48
Table 3
Transfection format
Plate format Total volume well RNP Complex sgRNA
24-well 550 μl 2.2 pmols 3.88 pmols
6-well 3 ml 10 pmols 17.66 pmols
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